Presentations from the Frontiers in Oncologic Prostate Care and Ablative Local Therapy

SESSION 1: PROSTATE IMAGING

Prostate MRI for the Urologist

Sadhna Verma, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 23, 2022.

The Manogram: Role of MRI in Prostate Cancer Screening

Peter Pinto, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 23, 2022.

SESSION 2: INTRODUCTION TO FOCAL THERAPY

Rationale for Focal Therapy

Samir Taneja, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 23, 2022.

Selecting Candidates for Focal Therapy

Abhinav Sidana, MD, MPH, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 23, 2022.

PET Imaging for Selection of Focal Therapy Candidates

Jeremie Calais, MD, MSc, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 23, 2022.

Focal Therapy vs. Active Surveillance for Low Volume GG2 Disease

Kara Watts, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 23, 2022.

Prostate Cancer Biomarkers and Focal Therapy

Minhaj Siddiqui, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 23, 2022.

Focal Therapy Can Be Done for MRI Invisible Disease

Leonard S. Marks, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 23, 2022.

Focal Therapy Should Not Be Done for MRI Invisible Disease

Jim Hu, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 23, 2022.

MR/US fusion vs. Systematic Biopsy for Prostate Cancer Diagnosis: The definitive
Phase II Trial

Inderbir S. Gill, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 23, 2022.

Panel Discussion: Optimal Imaging for Prostate Cancer Diagnosis and Staging

Abhinav Sidana, MD, MPH, moderated this panel during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 23, 2022.

Panelist: Caroline Moore, MD, Mark Emberton, MD, FRCS, Arvin K. George, MD, Peter Pinto, MD, Jeremie Calais, MD, MSc, Sadhna Verma, MD

The Unlikely Candidates: Focal Therapy for Low and High-Risk

Caroline Moore, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 23, 2022.

SESSION 3: PRINCIPLES OF FOCAL TREATMENT

Modalities, Maps and Margins: Optimizing Oncologic Efficacy

Mark Emberton, MD, FRCS presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 23, 2022.

Patient Safety: Operative Techniques to Minimize Morbidity

Lance Mynderse, MD, MS, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 23, 2022.

BALLOON DEBATE Round 1:
Optimal Management of Radio-Recurrent Unifocal Disease

Abhinav Sidana, MD, MPH moderated these lectures during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 23, 2022.

Active Surveillance: Arvin K. George, MD
Androgen Deprivation: Therapy Amir Lebatschi, MD
Cryo: Art Rastinehad, DO
HIFU: Caroline Moore, MD
Radiation: Amar Kishan, MD
Salvage Radical Prostatectomy: Peter Pinto, MD

BALLOON DEBATE Round 2:
Optimal Management of Radio-Recurrent Unifocal Disease

Abhinav Sidana, MD, MPH moderated these lectures during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 23, 2022.

Active Surveillance: Arvin K. George, MD
Cryo: Art Rastinehad, DO
HIFU: Caroline Moore, MD
Salvage Radical Prostatectomy: Peter Pinto, MD

BALLOON DEBATE Round 3:
Optimal Management of Radio-Recurrent Unifocal Disease

Abhinav Sidana, MD, MPH moderated these lectures during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 23, 2022.

Active Surveillance: Arvin K. George, MD
HIFU: Caroline Moore, MD

HANDS-ON COURSE I: STATE-OF-THE-ART BPH MANAGEMENT

Introduction – Workup/Guidelines

Amin Herati, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 24, 2022.

In-Office Water Vapor Ablation

Arvin K. George, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 24, 2022.

Prostatic Urethral Lift

Amin Herati, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 24, 2022.

Enucleation/HoLEP

Ayman Mahdy, MD, PhD, MBA, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 24, 2022.

Temporary Prostatic Nitinol Device

Paul Sethi, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 24, 2022.

Water Jet Ablation

Brian T. Helfand, MD, PhD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 24, 2022.

Summary

Amin Herati, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 24, 2022.

SESSION 4: SURVEILLANCE AND OUTCOME ASSESSMENT AFTER FOCAL THERAPY

Role of PSA and Biomarkers in Assessing Focal Therapy Success

Alexander P. Cole, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 24, 2022.

MRI Imaging After Focal Therapy: What and When?

Sadha Verma, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 24, 2022.

Protocol Biopsy for Surveillance After Focal Therapy

Kia Michel, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 24, 2022.

SESSION 5: FOCAL THERAPY CHALLENGES AND CASE DISCUSSIONS

Complications of Focal Therapy – Risk Factors, Timepoints, Management

Mark Emberton, MD, FRCS, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 24, 2022.

Mechanisms and Management of Recurrence

Samir Taneja, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 24, 2022.

Patient Reported Treatment Regret Following Partial Gland Cryo-ablation

Herbert Lepor, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 24, 2022.

Initial experience of the first in-human trial of focal laser ablation with ProFocal-Rx™ for localised prostate cancer

Jonathan Kam, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 24, 2022.

Case Discussions

Andre Abreu, MD, Mark Emberton, MD, FRCS, Caroline Moore, MD, and Laurence Klotz, MD, FRCSC, presented this case discussions during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 24, 2022.

Outcomes of Existing Focal Therapy Energy Modalities

Andre Abreu, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 24, 2022.

Combination of Prostate Ablation and Systemic Therapy in Prostate Cancer

Abhinav Sidana, MD, MPH, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 24, 2022.

Focal Therapy Society Update

Thomas J. Polascik, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 24, 2022.

SESSION 6: STARTING A FOCAL THERAPY PROGRAM

Block by Block: Building a Focal Therapy Program

Art Rastinehad, DO, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 24, 2022.

Billing and Reimbursement

Hugo Embert, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 24, 2022.

SESSION 7: WHAT’S ON THE HORIZON?

Navigating the Path to Approval

Minhaj Siddiqui, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 24, 2022.

Fusion-Guided Ablation with Koelis Promap-FT

Amir Lebatschi, MD, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 24, 2022.

Vanquish™ Water Vapor Ablation Technology

Michael Hoey, presented this lecture during the Frontiers in Oncologic Prostate Care and Ablative Local Therapy on September 24, 2022.